SOLV (Solventum) Construction In Progress : $375 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Solventum Construction In Progress?

Solventum's quarterly construction in progress increased from Sep. 2024 ($465 Mil) to Dec. 2024 ($504 Mil) but then declined from Dec. 2024 ($504 Mil) to Mar. 2025 ($375 Mil).

Solventum's annual construction in progress increased from Dec. 2022 ($240 Mil) to Dec. 2023 ($320 Mil) and increased from Dec. 2023 ($320 Mil) to Dec. 2024 ($504 Mil).

Solventum Construction In Progress Historical Data

The historical data trend for Solventum's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Construction In Progress Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

219.00

240.00

320.00

504.00

Solventum Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial							-	414.00	465.00	504.00	375.00

Solventum Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (NYSE:SOLV) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

SOLV:Mexico KB7:Germany

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.